Bristol-Myers Squibb Announces Dividend

NEW YORK, Sept. 11 The Board of Directors ofBristol-Myers Squibb Company (NYSE: BMY) today declared a quarterly dividendof twenty-eight cents ($0.28) per share on the $.10 par value Common Stock ofthe corporation. The quarterly dividend will be payable on November 1, 2007to stockholders of record at the close of business onOctober 5, 2007.

The Directors also declared a quarterly dividend of fifty cents ($0.50)per share on the $2.00 Convertible Preferred Stock of the corporation, payableDecember 3, 2007 to stockholders of record at the close of business onNovember 9, 2007.

Bristol-Myers Squibb Company is a global pharmaceutical and related healthcare products company whose mission is to extend and enhance human life.

SOURCE Bristol-Myers Squibb Company

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...